Multiple Manufacturers

BLEOMYCIN SULFATE

Manufacturer:

Multiple Manufacturers

Bleomycin Sulfate HCPCS:

J9040

HCPCS Code Descriptor:

Injection, bleomycin sulfate, 15 units

Category:

J Code

Bleomycin Sulfate NDCs:

00143-9241-01, 61703-0323-22, 00409-0323-20, 16714-0908-01, 63323-0137-20, 71288-0107-20, 00143-9240-01, 61703-0332-18, 00409-0332-20, 16714-0886-01, 63323-0136-10, 71288-0106-10

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Bleomycin Sulfate:

BLEOMYCIN SULFATE is an Oncology drug manufactured by Teva and administered via the Injection route of administration. The J Code: J9040 is aligned to the drug BLEOMYCIN SULFATE.

ACCESS PRICING AND MORE BY REGISTERING

J9040 Added Date:

January 1, 1984

J9040 Effective Date:

January 1, 2009

J9040 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Bleomycin Sulfate billing and coding information.
Our team did not identify a source for Bleomycin Sulfate patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for BLEOMYCIN SULFATE
Our team has not yet identified a source of side effects information for BLEOMYCIN SULFATE. Please check back in a few weeks.